Memphis, Tennessee – Juice Plus+ is proud to announce a research collaboration with the University of California LA, University College Cork (Ireland) and Ulster University (Northern Ireland).
For this randomized clinical trial, the University of California LA received a major research grant from the National Institutes of Health (NIH), a globally recognized institution of scientific excellence. The NIH, renowned for supporting only the highest caliber of medical research, has chosen to fund an innovative project aimed at better understanding critical cognitive functional parameters in the brain and related biomarkers, with the long-term goal of identifying factors influencing cognitive performance and overall well-being.
NIH grants are awarded following a rigorous review process by world-leading experts and scientists, ensuring only the most promising and evidence-based proposals receive support. As part of the US – Ireland R&D Partnership Programme, the University College Cork has also received a grant from Research Ireland, and Ulster University received a grant from the Health & Social Care R&D Division Northern Ireland. These fundings reflect peer recognition of the scientific approach being taken by the university researchers.
Research Focus and Endpoints*
This 5-year project is designed to evaluate the effects Juice Plus+® Berry Blend may have on brain and cognitive parameters and
Tag Archive for Clinical Trial
Hot Business News Today
LifeVantage Completes Successful Human Clinical Trial With New GLP-1 System
by Team Business For Home • • 0 Comments
LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, has completed its randomized, 12-week human clinical trial evaluating the efficacy of its innovative GLP-1 system for weight management. The study was conducted to explore the system’s potential to activate GLP-1 in users and support their health goals. * †
The clinical trial, which began in mid-June 2024, involved 60 participants and was designed to assess the impact the innovative two-product system has on weight management, food cravings, and overall well-being, among other factors. * †
Participants were divided into three groups to evaluate the system’s effects under different conditions, comparing the product system alone, the product system combined with diet and exercise guidance, and a control group, over the course of the three-month period.
“We are thrilled to have completed this key phase of our research and for the results we are seeing with these products,”
said Lisa Barnes, Vice President of Research, Development & Regulatory at LifeVantage.
“The data from this human clinical shows a remarkable ability of our unique two-product system to address weight management challenges through the natural activation of the health-supporting hormone, GLP-1. We remain confident that